Home page
MyAlcon for Consumers

My Alcon | UK | IE

This page is available in English. Select below for other locations.

Select Another Location
 

 

The Clareon® Collection of intraocular lenses (IOLs) deliver MORE solution for what matters most

 

The Clareon® Collection of intraocular lenses (IOLs) deliver MORE solution for what matters most

 

Clareon® PanOptix® Pro IOL

 

Discover MORE LIGHT utilization with less scatter1–3*

See More
Abstract glowing blue IOL silhouette hovering over a bioluminescent ocean at night, with rocky islands, star-filled sky, and neon light reflections creating a futuristic cosmic seascape.

Clareon® PanOptix® IOL

 

Delivers MORE RANGE of vision4† with a low visual disturbance profile5–12‡

Modern concert scene with a glowing blue see-through IOL silhouette overlay, live musicians performing on stage under neon purple and blue lights, and an audience recording the performance on a smartphone.

Clareon® Vivity® IOL

 

Presbyopia correction with a consistent monofocal visual disturbance profile13–15§

See More
Stylized blue-toned highway tunnel with sleek sports cars driving at high speed, with a glowing see-through IOL graphic.

Clareon® Monofocal and Clareon® Toric IOL

 

MORE than brilliant distance vision – also functional intermediate19^

See More
On a mostly blurred background, seen through an IOL graphic, there is a sailboat on the water during sunset, with a table set with drinks.

Alcon Experience Academy

 

For relevant training content from industry thought leaders

Visit AEA Portal

*Compared to Clareon® PanOptix®. Based on bench and vision simulator studies.
†Pooled mean binocular defocus curve at 3-6mo post op from 6 prospective trials on AcrySof® IQ PanOptix® in cataract patients.
‡AcrySof® IQ PanOptix® was tested. AcrySof® IQ PanOptix® and Clareon® PanOptix® are optically equivalent.
§Clinical studies were performed on the AcrySof® IQ Vivity® IOL; AcrySof® IQ Vivity® and Clareon® Vivity® are optically equivalent.
¶Compared to Clareon® Monofocal.
^Based on a study of patients who received Clareon® monofocal IOL in both eyes. Individual results may vary.

 

 

References:
1. Alcon data on file, 2024. [REF-25221].
2. Alcon data on file, 2024. [REF-25222].
3. Alcon data on file, 2025. [REF-25218].
4. Kohnen T, Lapid-Gortzak R, Ramamurthy D, et al. Clinical outcomes after bilateral implantation of a diffractive trifocal intraocular lens: A worldwide pooled analysis of prospective clinical investigations. Clin Ophthalmol. 2023;17:155-163.
5. Zhu D, Zhang J, et al. Patient-Reported Outcomes of Visual Disturbances with a Trifocal Intraocular Lens: A meta-analysis. Paper presented at: ASCRS Annual Meeting; April 5-8, 2024; Boston.
6. Clareon® PanOptix® Trifocal Hydrophobic Acrylic IOL. Product Information.
7. Alcon data on file, 2024. [REF-23958].
8. Alcon data on file, 2024. [REF-25441].
9. Alcon data on file, 2024. [REF-25903].
10. Alcon data on file, 2023. [REF-23561].
11. Sezgin Asena B. Visual and refractive outcomes, spectacle independence, and visual disturbances after cataract or refractive lens exchange surgery: Comparison of 2 trifocal intraocular lenses. J Cataract Refract Surg. 2019;45(11):1539–1546.
12. Alcon data on file, 2025. [REF-26324].
13. Clareon® Vivity® Extended Vision Hydrophobic IOL. Product Information.
14. Bala C, Poyales F, Guarro M, et al. Multicountry clinical outcomes of a new nondiffractive presbyopia-correcting IOL. J Cataract Refract Surg. 2022;48(2):136–143.
15. McCabe C, Berdahl J, Reiser H, et al. Clinical outcomes in a U.S. registration study of a new EDOF intraocular lens with a nondiffractive design. J Cataract Refract Surg. 2022;48(11):1297–1304.
16. Alcon data on file, 2025. [REF-28331].
17. Alcon data on file, 2025. [REF-28335].
18. Alcon data on file, 2025. [REF-28336].
19. Micheletti JM, Duncan NB, Hall B. Head-to-Head Comparison of Intermediate Vision of Two Monofocal Intraocular Lenses. Clin Ophthalmol. 2023;17:3983-3990.

© 2026 Alcon Inc. 05/26 CLUSTER-UKIE-CAT-2600001